Roche provides molecular testing solutions to identify and differentiate SARS-CoV-2 Omicron variants of concern
The Pharma Data
MARCH 16, 2022
2 subvariant is steadily increasing in prevalence, specifically in Denmark Use of these tests assess the spread of circulating variants and can help monitor the potential impact of therapeutics, vaccines and public health interventions All Roche SARS-Cov-2 tests correctly identify the virus including these new subvariants. 3 and Delta. “In
52 
Let's personalize your content